Table 4.
Cox Regression Analysis for Predictors of Loss to Follow-Up Among Children on ART in Northeast Ethiopia, 2020
| Variable | Status | CHR with CI | AHR with CI | P-value | |
|---|---|---|---|---|---|
| LTFU | Censored | ||||
| Age ≥5 years | 58(17%) | 283(83%) | 1 | 1 | |
| 1–5 years | 39(31.2%) | 86(68.8%) | 1.9(1.28,2.90) | 1.6(1.05, 2.46) | 0.030* |
| <1 years | 4(18.2%) | 18(81.8%) | 1.2(0.43, 3.28) | 0.6 (0.21,1.94) | 0.426 |
| Sex: Male | 71(27.5%) | 187(72.5%) | 2.4(1.55–3.65) | 2.1(1.37, 3. 34) | 0.001** |
| Female | 30(13%) | 200(87%) | 1 | 1 | |
| Residence: Urban | 66(17.8%) | 305 (82.2%) | 1 | 1 | |
| Rural | 35(29.9%) | 82(70.1%) | 2(1.34–3.04) | 1.3 (0.88,2.06) | 0.176 |
| Taking prophylaxis | |||||
| Yes | 88(19.5%) | 364 (80.5%) | 1 | 1 | |
| No | 13(36.1%) | 23(63.9%) | 2.7(1.52,4.91) | 0.9(0.46,1.71) | 0.718 |
| Regimen change | |||||
| Yes | 43(15.3%) | 238(84.7%) | 1 | 1 | |
| No | 58(28%) | 149(72%) | 4.3(2.84–6.41) | 4.1(2.59,6.45) | 0.000** |
| CD4 count | |||||
| ≥350 cells | 28(12.3%) | 199(87.7%) | 1 | 1 | |
| < 350 cells | 73(28%) | 188(72%) | 2 (1.28–3.06) | 1.5(0.93, 2.41) | 0.094 |
| Hemoglobin | |||||
| ≥10 mg/dl | 75(17.4%) | 356(82.6%) | 1 | 1 | |
| <10 mg/dl | 26(45.6%) | 31(54.4%) | 2.7(1.73, 4.23) | 1.3 (0.81, 2.16) | 0.267 |
| Height/L for age | |||||
| Normal | 63(15.6%) | 341(84.4%) | 1 | 1 | |
| Stunted | 38(45.2%) | 46(54.8%) | 3.6(2.38,5.39) | 2.2(1.43, 3.44) | 0.000** |
| WHO stage | |||||
| Stage I &II | 42(13.8%) | 263(86.2%) | 1 | 1 | |
| Stage III&IV | 59(32.2%) | 124(67.8%) | 2.1(1.43,3.16) | 2.2(1.40,3.34) | 0.000** |
| Treatment adherence | |||||
| Good | 53(13.1%) | 353(86.9%) | 1 | 1 | |
| Fair | 12(31.6%) | 26(68.4%) | 2.8(1.50,5.26) 8.6(5.64, | 2.2 (1.14,4.20) | 0.019* |
| Poor | 36(81.8%) | 8(18.2%) | 13.2) | 6.6(4.11,10.56) | 0.000** |
Notes: *Statistically significant predictors. **Statistically highly significant predictors.